tetano
Editor, Senior Moderator
Vaccine
In Press, Uncorrected Proof - Note to users
doi:10.1016/j.vaccine.2011.10.044 | How to Cite or Link Using DOI
Discussion
The influence of the stigma of obesity on H1N1 influenza vaccine sequencing in Canada in 2009
Chris Kaposy Corresponding Author Contact Information, E-mail The Corresponding Author
Division of Community Health and Humanities, Faculty of Medicine, Memorial University of Newfoundland, Health Sciences Centre, Room 2830, St. John's NL, A1B 3V6, Canada
Received 10 August 2011; revised 12 October 2011; Accepted 18 October 2011. Available online 30 October 2011.
Abstract
In 2009, the Public Health Agency of Canada (PHAC) provided guidelines about which groups should be given first access to the H1N1 influenza vaccine. These guidelines recommended that people under 65 with chronic health conditions should be among the first groups to receive the H1N1 influenza vaccine. Severe obesity was among the relevant chronic health conditions identified by PHAC. Since health care is under the jurisdiction of the ten Canadian provinces, the provinces were not required to follow these recommendations in their respective mass vaccination campaigns. Only one province (Manitoba) followed the PHAC recommendations with respect to severe obesity. Four provinces did not offer early vaccination to this group. Other provinces listed severe obesity as a sequencing category late in the vaccination campaign or placed narrow age restrictions on those who were given early access. This commentary argues that the Canadian provinces demonstrated an ambiguous commitment to the early vaccination of people who were severely obese, and that there is evidence that the stigma of obesity influenced H1N1 influenza vaccine sequencing decisions in many Canadian provinces.
http://www.sciencedirect.com/science/article/pii/S0264410X11016641
In Press, Uncorrected Proof - Note to users
doi:10.1016/j.vaccine.2011.10.044 | How to Cite or Link Using DOI
Discussion
The influence of the stigma of obesity on H1N1 influenza vaccine sequencing in Canada in 2009
Chris Kaposy Corresponding Author Contact Information, E-mail The Corresponding Author
Division of Community Health and Humanities, Faculty of Medicine, Memorial University of Newfoundland, Health Sciences Centre, Room 2830, St. John's NL, A1B 3V6, Canada
Received 10 August 2011; revised 12 October 2011; Accepted 18 October 2011. Available online 30 October 2011.
Abstract
In 2009, the Public Health Agency of Canada (PHAC) provided guidelines about which groups should be given first access to the H1N1 influenza vaccine. These guidelines recommended that people under 65 with chronic health conditions should be among the first groups to receive the H1N1 influenza vaccine. Severe obesity was among the relevant chronic health conditions identified by PHAC. Since health care is under the jurisdiction of the ten Canadian provinces, the provinces were not required to follow these recommendations in their respective mass vaccination campaigns. Only one province (Manitoba) followed the PHAC recommendations with respect to severe obesity. Four provinces did not offer early vaccination to this group. Other provinces listed severe obesity as a sequencing category late in the vaccination campaign or placed narrow age restrictions on those who were given early access. This commentary argues that the Canadian provinces demonstrated an ambiguous commitment to the early vaccination of people who were severely obese, and that there is evidence that the stigma of obesity influenced H1N1 influenza vaccine sequencing decisions in many Canadian provinces.
http://www.sciencedirect.com/science/article/pii/S0264410X11016641